CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COMMON STOCK
Shares outstanding
123,180,519
Total 13F shares
27,154,228
Share change
+2,868,355
Total reported value
$80,663,000
Put/Call ratio
0%
Price per share
$2.97
Number of holders
48
Value change
+$8,338,316
Number of buys
21
Number of sells
21

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2014

As of 31 Dec 2014, CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,154,228 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, Broadfin Capital, LLC, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, SPHERA FUNDS MANAGEMENT LTD., Opaleye Management Inc., Catalyst Capital Advisors LLC, and Private Capital Advisors, Inc.. This page lists 47 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.